Breakthrough fetal surgery uses placental stem cells to help babies with spina bifida walk

NCT ID NCT04652908

First seen Jan 10, 2026 · Last updated Apr 21, 2026 · Updated 16 times

Summary

This study is testing whether adding living stem cells from placenta to fetal surgery for spina bifida can improve babies' ability to walk. The stem cells may protect the developing spinal cord and potentially reverse some nerve damage. Researchers will assess safety and whether this approach improves motor function and walking ability compared to surgery alone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYELOMENINGOCELE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UC Davis Health

    RECRUITING

    Sacramento, California, 95817, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.